Abstract GS3-09: GS3-09 Circulating Tumor Cells-driven Choice of First Line Therapy for ER+ HER2- Metastatic Breast Cancer: Overall Survival Analysis of the Randomized STIC CTC TrialFrancois-Clement Bidard,Nicolas Kiavue,Catherine Alix-Panabières,Sylvain Dureau,Thomas Bachelot,Hugues Bourgeois,Anthony Gonçalves,Etienne Brain,Sylvain Ladoire,Florence Dalenc,Joseph Gligorov,Luis Teixeira,George Emile,Jean-Marc Ferrero,Delphine Loirat,Luc Cabel,Véronique Diéras,Frédérique Berger,William Jacot,Jean-Yves PiergaCancer Research（2023）引用 1|浏览26AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
